http://www.biolabindia.co.in/blog/ Latest Products Fri, 26 Apr 2024 06:43:51 +0530 en-us http://www.biolabindia.co.in http://www.biolabindia.co.in/blog/availability-of-ppe-kits-n95-masks-and-ventilators-amidst-covid-19_11833.htm Wed, 24 Nov 2021 16:58:24 +0530 The prevention, containment and management of COVID-19 in the country are being monitored at the highest level and various actions have been initiated in collaboration with the States. In order to meet the requirement of PPEs, masks and ventilators, factories producing essential items are working round the clock and ordinance factories are trying to produce personal protection equipment for medical personnel. While Bharat Electronics Limited is going to manufacture ventilators, all drug companies have assured the government that there will not be any shortage of drugs during this crisis and even auto manufacturers are working to develop and produce ventilators. Medical personnel are being trained and are fully prepared for any emergencies. Personal protection equipment (PPE) kits are used by medical personnel working in isolation areas and intensive care units to protect them from acquiring infections. They were not being manufactured in the country. With the prospect of huge requirement of PPEs arising in the near future, the Government of India made proactive efforts to promote their manufacturing in the country. Ministry of Textiles and Ministry of Health and Family Welfare have been working together in this endeavour. Domestic manufacturers rose to the occasion and so far 11 manufacturers have cleared quality tests. Orders for 21 lakh PPE coveralls have been placed on them. Currently they are supplying 6-7,000 coveralls per day and this is expected to go up to 15,000 per day within the next week. One more manufacturer has qualified today and an order of 5 lakh coveralls has been placed with him. As of now, 3.34 lakh PPEs are available in various hospitals across the country. About 60,000 PPE kits have already been procured and supplied by Government of India. Indian Red cross society has arranged 10,000 PPEs from China which have also been received and are being distributed. Another 3 lakh donated PPE coveralls are to arrive by 4th April. An order for 3 lakh PPEs has been placed with ordinance factories. Foreign sources of PPE kits are also faced with a huge increase in the worldwide demand. They are being approached through the Ministry of External Affairs. A Singapore based online platform has been identified which can supply 10 lakh PPE kits and an order has been placed through Ministry of External Affairs to procure them. Another supplier based in Korea, who has tie ups with production companies in Vietnam and Turkey has been identified with daily production capacity of over 1 lakh PPE kits.Orders arebeing placed on this company through MEA for supplying 20 lakh PPE kits. N95 masks are being manufactured by two domestic producers. They are able to supply 50,000 masks per day at the moment, but are ramping up capacities to make 1 lakh masks per day within the next week. DRDO is also collaborating with local manufacturers to produce about 20,000 N99 masks per day. This supply is also expected to become available in a week’s time. Hospitals in the country have 11.95 lakh N95 masks in stock as of now. Additional 5 lakh masks were distributed in the past two days and 1.40 lakh masks are being distributed today. 10 lakh masks would be part of the PPE kits being sourced from Singapore. Ventilators are required for Covid-19 patients, as they tend to develop acute respiratory disease syndrome (ARDS). Less than 20 covid-19 patients are on ventilator support at this moment. As against this, over 14,000 ventilators have been identified in various hospitals across the country for treatment of covid-19 patients. A domestic manufacturers Agva Healthcare in Noida has been able to develop suitable ventilators and an order of 10,000 ventilators has been placed on him.Supplies are expected to commence by the 2nd week of April. In addition, an order for 30,000 ventilators has been placed on Bharat Electronics Limited which is going to collaborate with domestic manufacturers in this endeavour. Indian Auto manufacturers are also preparing to manufacture ventilators. In the meantime, orders have been placed on international companies like Hamilton, Mindray and Draeger to supply ventilators. Ministry of External Affairs is also approaching suppliers in China for sourcing 10,000 ventilators from them. http://www.biolabindia.co.in/blog/wearing-of-masks-made-mandatory-in-bengaluru_11834.htm Wed, 24 Nov 2021 16:59:58 +0530  Not wearing a mask in public places in Bengaluru will be treated as a public offense, attracting a penalty of Rs 1,000 the first time and Rs 2,000 the subsequent times.  As per the new regulations that came into effect on May 1, 2020, wearing facial masks covering the mouth and nose in public places and work places with more than five employees in Bengaluru has been made compulsory.   According to media reports, the Bengaluru civic body order has also made it mandatory that gloves and masks used in households and commercial establishments be handed over to waste collectors in covers or sealed bags as part of sanitary waste. http://www.biolabindia.co.in/blog/new-philips-respironics-e30-ventilator-to-help-free-up-icu-units-in-wake-of-covid_11835.htm Wed, 24 Nov 2021 17:01:05 +0530 Philips  today announced its initiative to quickly scale production of its new  Philips Respironics E30 ventilator as a readily available ventilation  alternative during the COVID-19 crisis in situations where  full-featured, critical care ventilators are not available. Philips will  begin production immediately, ramping up outputs on an ongoing basis  with expectations of producing 15,000 units per week in April, 2020.   Designed for mass production by a team deeply experienced in respiratory care, the E30 ventilator features include: The ability to use the device both invasively and non-invasively; Quick  set-up and simple operations, allowing healthcare providers with a wide  range of skill sets to treat and monitor patients in clinical and  field-hospital settings; The ability to accept high-flow oxygen; Recommended  circuit set-ups contain a bacterial/viral filter to minimize exposure  for healthcare providers when used invasively or noninvasively with  example accessories that may be used, such as a full-face, non-vented  (without integrated leak) mask, or helmet;   On-screen  respiratory monitoring to measure and display vital ventilation type  parameters such as pressure, tidal volume, respiratory rate, leak, and  oxygen saturation, enabling clinicians to evaluate therapy  effectiveness;   Visual and audible alarms to provide pertinent therapy information to healthcare providers.     Philips  is responding to this pressing global need by quickly scaling  production of the new Philips Respironics E30 ventilator with the needs  of healthcare workers and COVID-19 patients in mind while also complying  with medical device quality standards. David White, Chief Scientific Officer at Philips Sleep and Respiratory Care.   “As  COVID-19 continues to spread globally, healthcare providers are working  diligently to treat soaring numbers of patients at a time when there  are too few ventilators to provide care,” said David White, Chief  Scientific Officer at Philips Sleep and Respiratory Care. “Philips is  responding to this pressing global need by quickly scaling production of  the new Philips Respironics E30 ventilator with the needs of healthcare  workers and COVID-19 patients in mind while also complying with medical  device quality standards. Our hope is that this solution will help to  free-up ICU ventilators for use in treating the most severe patients.”    Philips  has received Emergency Use Authorization (EUA) for the device for use  only during the COVID public emergency. Status of EUA requests can be  found on the FDA website. The Philips Respironics E30 is not FDA cleared  or approved.    Philips  is working with the relevant regulatory authorities to distribute the  device globally for purchase by governments and hospitals who are  experiencing ventilator shortages.  http://www.biolabindia.co.in/blog/agva-healthcare-teams-up-with-maruti-suzuki-to-make-low-cost-ventilators_11836.htm Wed, 24 Nov 2021 17:02:32 +0530 AgVa Healthcare has joined hands with Maruti Suzuki to ramp up production of ventilators after the government called on all firms to contribute to the anti-coronavirus effort.   An AgVa ventilator weighs only 3.5 kg and helps move less-critical patients back to their homes as the machine is easy to transport and install, and does not need much power.   Ventilators pump air into the lungs and are critical for hospitals as they are swamped with COVID-19 cases. Reports say India only has about 40,000 ventilators.   According to media reports, AgVa’s target is to produce 20,000 COVID-19 ventilators per month, and later increase production to six digits. The company has an order book of about 17,000 ventilators.   As the death toll due to fresh coronavirus mounts across the country, which is under lockdown, AgVa is increasing production at both its units in Noida bordering the outskirts of the national capital.   While Maruti will help scale up production, the ventilator will remain a product of AgVa.  The ventilator runs on room air without the need of compressed medical air. It can deliver 100 per cent fraction of inspired oxygen (FIO2) when connected to an oxygen source. http://www.biolabindia.co.in/blog/agva-healthcare-teams-up-with-maruti-suzuki-to-make-low-cost-ventilators_11837.htm Wed, 24 Nov 2021 17:02:32 +0530 AgVa Healthcare has joined hands with Maruti Suzuki to ramp up production of ventilators after the government called on all firms to contribute to the anti-coronavirus effort.   An AgVa ventilator weighs only 3.5 kg and helps move less-critical patients back to their homes as the machine is easy to transport and install, and does not need much power.   Ventilators pump air into the lungs and are critical for hospitals as they are swamped with COVID-19 cases. Reports say India only has about 40,000 ventilators.   According to media reports, AgVa’s target is to produce 20,000 COVID-19 ventilators per month, and later increase production to six digits. The company has an order book of about 17,000 ventilators.   As the death toll due to fresh coronavirus mounts across the country, which is under lockdown, AgVa is increasing production at both its units in Noida bordering the outskirts of the national capital.   While Maruti will help scale up production, the ventilator will remain a product of AgVa.  The ventilator runs on room air without the need of compressed medical air. It can deliver 100 per cent fraction of inspired oxygen (FIO2) when connected to an oxygen source. http://www.biolabindia.co.in/blog/fast-track-approval-for-indian-covid-19-testing-kits-for-commercial-use_11838.htm Wed, 24 Nov 2021 17:03:28 +0530 New Delhi : ICMR has recommended two RT-PCR (Reverse transcription polymerase chain reaction) test kits for use in ICMR approved government and private laboratories. These test kits have been found to have 100% concordance among true positive and true negative samples. The details in annexure includes all the kits tests as on date.    ICMR has established a fast-track mechanism for validation of non-US FDA EUA/CE IVD approved kits at ICMR NIV Pune. ICMR NIV Pune has completed evaluation of 09 non-US FDA EUA/CE IVD kits. Only test kits with 100% concordance among true positive and true negative samples have been recommended for commercial use in India.    In addition to the above US FDA EUA/CE IVD approved kits can be used directly after due approval from DCGI and intimation to ICMR